{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T10:59:09Z","timestamp":1777805949690,"version":"3.51.4"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2016-COG-726061"],"award-info":[{"award-number":["ERC-2016-COG-726061"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/137766\/2018"],"award-info":[{"award-number":["SFRH\/BD\/137766\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jare.2022.11.008","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:06:33Z","timestamp":1670249193000},"page":"149-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Extracellular matrix in skin diseases: The road to new therapies"],"prefix":"10.1016","volume":"51","author":[{"given":"M.D.","family":"Malta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.P.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2022.11.008_b0005","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jare.2022.11.008_b0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.autrev.2011.05.017","article-title":"Autoimmune blistering diseases of the skin","volume":"11","author":"Sticherling","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jare.2022.11.008_b0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev-genom-090314-050039","article-title":"The Genetics of Soft Connective Tissue Disorders","volume":"16","author":"Vanakker","year":"2015","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0020","first-page":"129","author":"Malfait","year":"2014","journal-title":"The Ehlers-Danlos Syndrome"},{"key":"10.1016\/j.jare.2022.11.008_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940600007X","article-title":"Elastic fibres in health and disease","volume":"8","author":"Baldwin","year":"2006","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.jare.2022.11.008_b0030","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00281-019-00759-y","article-title":"Resolution in bullous pemphigoid","volume":"41","author":"Sadik","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jare.2022.11.008_b0040","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/1523-1747.ep12292701","article-title":"Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida","volume":"108","author":"B\u00e9dane","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1525-1470.2008.00817.x","article-title":"Childhood linear IgA bullous dermatosis in Tunisia","volume":"26","author":"Kenani","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9440(10)64182-X","article-title":"Autoantibodies to type VII collagen mediate Fc\u03b3-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin","volume":"161","author":"Sitaru","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2022.11.008_b0055","first-page":"120","article-title":"Epidemiology of skin cancer","volume":"810","author":"Leiter","year":"2014","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.jare.2022.11.008_b0060","doi-asserted-by":"crossref","unstructured":"Naba A, Clauser KR, Hoersch S, Liu H, Carr SA, Hynes RO. The matrisome: In silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Molecular and Cellular Proteomics 2012;11. https:\/\/doi.org\/10.1074\/mcp.M111.014647.","DOI":"10.1074\/mcp.M111.014647"},{"key":"10.1016\/j.jare.2022.11.008_b0065","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jare.2022.11.008_b0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pop.2015.07.006","article-title":"Skin Cancer","volume":"42","author":"Linares","year":"2015","journal-title":"Primary Care - Clinics in Office Practice"},{"key":"10.1016\/j.jare.2022.11.008_b0075","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.17873","article-title":"Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013\u201315: a cohort study","volume":"181","author":"Venables","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0080","doi-asserted-by":"crossref","unstructured":"Malfait F, Symoens S, Goemans N, Gyftodimou Y, Holmberg E, L\u00f3pez-Gonz\u00e1lez V, et al. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an Osteogenesis Imperfecta\/Ehlers-Danlos Syndrome overlap syndrome. Orphanet Journal of Rare Diseases 2013 8:1 2013;8:1\u201310. https:\/\/doi.org\/10.1186\/1750-1172-8-78.","DOI":"10.1186\/1750-1172-8-78"},{"key":"10.1016\/j.jare.2022.11.008_b0085","doi-asserted-by":"crossref","first-page":"19259","DOI":"10.1074\/jbc.M414698200","article-title":"Mutations near amino end of \u03b11(I) collagen cause combined osteogenesis imperfecta\/Ehlers-Danlos syndrome by interference with N-propeptide processing","volume":"280","author":"Cabral","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2022.11.008_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-016-1087-0","article-title":"Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report","volume":"10","author":"Cortini","year":"2016","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jare.2022.11.008_b0095","doi-asserted-by":"crossref","unstructured":"D\u2019hondt S, Guillemyn B, Syx D, Symoens S, De Rycke R, Vanhoutte L, et al. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model. Matrix Biology 2018;70:72\u201383. https:\/\/doi.org\/10.1016\/j.matbio.2018.03.008.","DOI":"10.1016\/j.matbio.2018.03.008"},{"key":"10.1016\/j.jare.2022.11.008_b0100","doi-asserted-by":"crossref","unstructured":"N\u00f8rremark K, Pharma L, Lebwohl M, Gracia-Caza\u223c Na T, De Barbastro H, Salazar N, et al. Collagen type V expression and localization in aging skin. J Am Acad Dermatol 2017;76:AB75. https:\/\/doi.org\/10.1016\/J.JAAD.2017.04.308.","DOI":"10.1016\/j.jaad.2017.04.308"},{"key":"10.1016\/j.jare.2022.11.008_b0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jcb.20024","article-title":"Reduced type I collagen utilization: A pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome","volume":"92","author":"Wenstrup","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jare.2022.11.008_b0110","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.0022-202X.2005.23727.x","article-title":"A novel mutation in the lysyl hydroxylase 1 gene causes decreased lysyl hydroxylase activity in an ehlers-danlos VIA patient","volume":"124","author":"Walker","year":"2005","journal-title":"J, Invest Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.matbio.2013.10.012","article-title":"Mechanical recruitment of N- and C-crosslinks in collagen type I","volume":"34","author":"Kwansa","year":"2014","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jare.2022.11.008_b0120","doi-asserted-by":"crossref","first-page":"34397","DOI":"10.1074\/jbc.M506458200","article-title":"Domains and maturation processes that regulate the activity of ADAMTS-2, a metalloproteinase cleaving the aminopropeptide of fibrillar procollagens types I-III and V","volume":"280","author":"Colige","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2022.11.008_b0125","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/genes10110843","article-title":"Clinical and molecular characterization of classical-like ehlers-danlos syndrome due to a novel TNXB variant","volume":"10","author":"Rymen","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jare.2022.11.008_b0130","doi-asserted-by":"crossref","unstructured":"Delbaere S, Dhooge T, Syx D, Petit F, Goemans N, Destr\u00e9e A, et al. Novel defects in collagen XII and VI expand the mixed myopathy\/Ehlers\u2013Danlos syndrome spectrum and lead to variant-specific alterations in the extracellular matrix. Genetics in Medicine 2019;0. https:\/\/doi.org\/10.1038\/s41436-019-0599-6.","DOI":"10.1038\/s41436-019-0599-6"},{"key":"10.1016\/j.jare.2022.11.008_b0135","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/humu.21300","article-title":"Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome","volume":"31","author":"Miyake","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jare.2022.11.008_b0140","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1093\/hmg\/ddy234","article-title":"Biallelic B3GALT6 mutations cause spondylodysplastic Ehlers-Danlos syndrome","volume":"27","author":"Van Damme","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0145","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1369\/0022155412459857","article-title":"Iduronic Acid in Chondroitin\/Dermatan Sulfate: Biosynthesis and Biological Function","volume":"60","author":"Malmstr\u00f6m","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jare.2022.11.008_b0150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/humu.22774","article-title":"Genetic heterogeneity and clinical variability in musculocontractural ehlers-danlos syndrome caused by impaired dermatan sulfate biosynthesis","volume":"36","author":"Syx","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jare.2022.11.008_b0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/humu.21462","article-title":"New insights into the pathogenesis of autosomal dominant cutis laxa with report of five ELN mutations","volume":"32","author":"Callewaert","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jare.2022.11.008_b0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1248\/jhs.52.259","article-title":"Biochemical Analysis of Elastic Fiber Formation with a Frameshift-Mutated Tropoelastin (fmTE) at the C-Terminus of Tropoelastin","volume":"52","author":"Sato","year":"2006","journal-title":"J Health Sci"},{"key":"10.1016\/j.jare.2022.11.008_b0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/415171a","article-title":"Fibulin-5\/DANCE is essential for elastogenesis in vivo","volume":"415","author":"Nakamura","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jare.2022.11.008_b0170","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/MCB.26.5.1700-1709.2006","article-title":"Targeted Disruption of Fibulin-4 Abolishes Elastogenesis and Causes Perinatal Lethality in Mice","volume":"26","author":"McLaughlin","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jare.2022.11.008_b0175","doi-asserted-by":"crossref","unstructured":"Alanazi YF, Lockhart-Cairns MP, Cain SA, Jowitt TA, Weiss AS, Baldock C. Autosomal Recessive Cutis Laxa 1C Mutations Disrupt the Structure and Interactions of Latent TGF\u03b2 Binding Protein-4. Front Genet 2021;12. https:\/\/doi.org\/10.3389\/FGENE.2021.706662.","DOI":"10.3389\/fgene.2021.706662"},{"key":"10.1016\/j.jare.2022.11.008_b0180","doi-asserted-by":"crossref","first-page":"21443","DOI":"10.1074\/jbc.M115.640425","article-title":"Fibulin-4 E57K Knock-in Mice Recapitulate Cutaneous, Vascular and Skeletal Defects of Recessive Cutis Laxa 1B with both Elastic Fiber and Collagen Fibril Abnormalities","volume":"290","author":"Igoucheva","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2022.11.008_b0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1267\/ahc.10026","article-title":"Fibulin-4 and -5, but not Fibulin-2, are Associated with Tropoelastin Deposition in Elastin-Producing Cell Culture","volume":"43","author":"Yamauchi","year":"2010","journal-title":"Acta Histochem Cytochem"},{"key":"10.1016\/j.jare.2022.11.008_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20050368","article-title":"Fibulin-5 interacts with fibrillin-1 molecules and microfibrils","volume":"388","author":"Freeman","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.jare.2022.11.008_b0195","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/hmg\/11.18.2113","article-title":"Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa","volume":"11","author":"Loeys","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0200","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ajhg.2009.09.013","article-title":"Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development","volume":"85","author":"Urban","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0205","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1242\/dmm.026005","article-title":"Function of Ltbp-4L and fibulin-4 in survival and elastogenesis in mice","volume":"9","author":"Bultmann-Mellin","year":"2016","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jare.2022.11.008_b0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajhg.2016.12.010","article-title":"Mutations in ATP6V1E1 or ATP6V1A Cause Autosomal-Recessive Cutis Laxa","volume":"100","author":"Van Damme","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0215","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/hmg\/ddp148","article-title":"Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival","volume":"18","author":"Hucthagowder","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0220","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ejhg.2013.154","article-title":"Clinical and biochemical features guiding the diagnostics in neurometabolic cutis laxa","volume":"22","author":"Gardeitchik","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0225","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ajhg.2009.07.001","article-title":"RIN2 Deficiency Results in Macrocephaly, Alopecia, Cutis Laxa, and Scoliosis: MACS Syndrome","volume":"85","author":"Basel-Vanagaite","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0230","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ejpn.2014.01.003","article-title":"Cutis laxa, fat pads and retinopathy due to ALDH18A1 mutation and review of the literature","volume":"18","author":"Wolthuis","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jare.2022.11.008_b0235","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ymgme.2013.08.009","article-title":"Genotype-phenotype spectrum of PYCR1-related autosomal recessive cutis laxa","volume":"110","author":"Dimopoulou","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jare.2022.11.008_b0240","first-page":"637","article-title":"Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients","volume":"164","author":"Bolling","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0245","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1083\/jcb.115.6.1661","article-title":"A function for keratins and a common thread among different types of epidermolysis bullosa simplex diseases","volume":"115","author":"Coulombe","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jare.2022.11.008_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-016-0314-7","article-title":"Downstream effects of plectin mutations in epidermolysis bullosa simplex with muscular dystrophy","volume":"4","author":"Winter","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jare.2022.11.008_b0255","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1046\/j.1523-1747.2002.19609.x","article-title":"Deletion of a cytoplasmic domain of integrin \u03b24 causes epidermolysis bullosa simplex","volume":"119","author":"Jonkman","year":"2002","journal-title":"J, Invest Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0260","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.ymthe.2020.03.006","article-title":"Gentamicin Induces Laminin 332 and Improves Wound Healing in Junctional Epidermolysis Bullosa Patients with Nonsense Mutations","volume":"28","author":"Kwong","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jare.2022.11.008_b0265","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bjd.18921","article-title":"Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility","volume":"183","author":"Has","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0270","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4161\/cam.22418","article-title":"Laminin 332 in junctional epidermolysis bullosa","volume":"7","author":"Kiritsi","year":"2013","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.jare.2022.11.008_b0275","first-page":"1","article-title":"Junctional epidermolysis bullosa: Allelic heterogeneity and mutation stratification for precision medicine","volume":"6","author":"Condrat","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jare.2022.11.008_b0280","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.matbio.2010.10.005","article-title":"Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332","volume":"30","author":"Van den Bergh","year":"2011","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jare.2022.11.008_b0285","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/ced.13407","article-title":"Seven novel COL7A1 mutations identified in patients with recessive dystrophic epidermolysis bullosa from Mexico","volume":"43","author":"Saeidian","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jmg.2006.045302","article-title":"Epidermolysis bullosa. II. Type VII collagen mutations and phenotype\u2013genotype correlations in the dystrophic subtypes","volume":"44","author":"Varki","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0295","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/hmg\/ddg097","article-title":"Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome","volume":"12","author":"Jobard","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jare.2022.11.008_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065341","article-title":"Kindlin-1 Regulates Integrin Dynamics and Adhesion Turnover","volume":"8","author":"Margadant","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2022.11.008_b0305","doi-asserted-by":"crossref","unstructured":"Matsumura K, Amagai M, Nishikawa T, Hashimoto T. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Archives of Dermatological Research 1996 288:9 1996;288:507\u20139. https:\/\/doi.org\/10.1007\/BF02505245.","DOI":"10.1007\/s004030050093"},{"key":"10.1016\/j.jare.2022.11.008_b0310","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2007.08.008","article-title":"Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid","volume":"49","author":"Ishiura","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jare.2022.11.008_b0320","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jare.2022.11.008_b0325","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.3389\/fimmu.2018.02687","article-title":"Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients","volume":"9","author":"Chiorean","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2022.11.008_b0330","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid. Allergy: European","volume":"72","author":"de Graauw","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jare.2022.11.008_b0335","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous Pemphigoid Autoantibodies Directly Induce Blister Formation without Complement Activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2022.11.008_b0340","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ajpath.2012.11.029","article-title":"Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway","volume":"182","author":"Hiroyasu","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2022.11.008_b0345","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1523-1747.2000.00141.x","article-title":"Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes","volume":"115","author":"Schmidt","year":"2000","journal-title":"J, Invest Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0350","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-Independent Effects of IgE and IgG Autoantibodies in Bullous Pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2022.11.008_b0355","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0360","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0365","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","article-title":"Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity","volume":"154","author":"Oyama","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0370","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1172\/JCI116033","article-title":"Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domloge-Hultsch","year":"1992","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jare.2022.11.008_b0375","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-4362.1985.tb05853.x","article-title":"Linear IgA Bullous Dermatosis: An Immunologically Defined Disease","volume":"24","author":"Wilson","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0380","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4049\/jimmunol.1101763","article-title":"Blocking Fc\u03b1 Receptor I on Granulocytes Prevents Tissue Damage Induced by IgA Autoantibodies","volume":"189","author":"van der Steen","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jare.2022.11.008_b0385","first-page":"9","article-title":"Specific inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice","author":"Mihai","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2022.11.008_b0390","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor Metastasis: Molecular Insights and Evolving Paradigms The Invasion-Metastasis Cascade","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jare.2022.11.008_b0395","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.ajpath.2012.08.027","article-title":"TGF-\u03b2 signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells","volume":"181","author":"Yin","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2022.11.008_b0400","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1074\/jbc.M111.336073","article-title":"The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens","volume":"287","author":"Behrens","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2022.11.008_b0405","first-page":"1041","article-title":"The expression of heparanase in non-melanoma skin cancer and its clinical significance","author":"He","year":"2010","journal-title":"Journal of Chinese Physician"},{"key":"10.1016\/j.jare.2022.11.008_b0410","doi-asserted-by":"crossref","first-page":"74678","DOI":"10.18632\/oncotarget.12492","article-title":"The prognostic significance of heparanase expression in metastatic melanoma","volume":"7","author":"Vornicova","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jare.2022.11.008_b0415","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/onc.2015.40","article-title":"Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity","volume":"34","author":"Yang","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2022.11.008_b0420","volume":"vol. 74","author":"Boyango","year":"2014","journal-title":"Heparanase cooperates with Ras to drive breast and skin tumorigenesis"},{"key":"10.1016\/j.jare.2022.11.008_b0425","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1747.2001.01241.x","article-title":"Cancer cell expression of urokinase-type plasminogen activator receptor mRNA in squamous cell carcinomas of the skin","volume":"116","author":"R\u00f8mer","year":"2001","journal-title":"JInvest Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0430","first-page":"70","article-title":"Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression","volume":"144","author":"de Vries","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2022.11.008_b0435","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2133.2008.08576.x","article-title":"Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction","volume":"159","author":"Ogura","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0440","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1074\/jbc.274.19.13066","article-title":"Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin\/Stromelysin-1 Cascade Enhances Tumor Cell Invasion","volume":"274","author":"Ramos-DeSimone","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2022.11.008_b0445","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1242\/jcs.114.1.111","article-title":"Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1","volume":"114","author":"Noe","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jare.2022.11.008_b0450","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)65023-7","article-title":"E-Cadherin Expression in Melanoma Cells Restores Keratinocyte-Mediated Growth Control and Down-Regulates Expression of Invasion-Related Adhesion Receptors","volume":"156","author":"Hsu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2022.11.008_b0455","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0625.2003.120201.x","article-title":"Matrix metalloproteinases in tumor progression: Focus on basal and squamous cell skin cancer","volume":"12","author":"Kerkel\u00e4","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0460","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1346-8138.2000.tb02172.x","article-title":"E-cadherin Expression in Skin Tumors Using an AMeX Immunohistostaining Method","volume":"27","author":"Koseki","year":"2000","journal-title":"J Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0465","first-page":"771","article-title":"HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer","volume":"38","author":"Greco","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jare.2022.11.008_b0470","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.prp.2013.08.002","article-title":"Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma","volume":"209","author":"Poswar","year":"2013","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.jare.2022.11.008_b0475","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1066896914540998","article-title":"Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma","volume":"23","author":"de Oliveira","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.jare.2022.11.008_b0480","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.yexmp.2012.01.003","article-title":"Differential expression patterns of MMPs and their role in the invasion of epithelial premalignant tumors and invasive cutaneous squamous cell carcinoma","volume":"92","author":"Roh","year":"2012","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jare.2022.11.008_b0485","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ijc.1636","article-title":"High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma","volume":"97","author":"Nikkola","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2022.11.008_b0490","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2133.2006.07678.x","article-title":"Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma","volume":"156","author":"Kawasaki","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0495","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1038\/onc.2009.272","article-title":"A Matrix Metalloproteinase-1\/Protease Activated Receptor-1 signaling axis promotes melanoma invasion and metastasis","volume":"28","author":"Blackburn","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jare.2022.11.008_b0500","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1182\/blood.V92.10.3694","article-title":"Protease-Activated Receptor 1 (PAR-1) Is Required and Rate-Limiting for Thrombin-Enhanced Experimental Pulmonary MetastasisPresented at the 39th Annual Meeting of the American Society of Hematology, San Diego, CA, December 8, 1997","volume":"92","author":"Nierodzik","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jare.2022.11.008_b0505","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1158\/0008-5472.CAN-08-2397","article-title":"Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA","volume":"68","author":"Villares","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2022.11.008_b0510","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.biocel.2008.11.008","article-title":"Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism","volume":"41","author":"Chalkiadaki","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jare.2022.11.008_b0515","first-page":"341","article-title":"Vascular endothelial growth factor-A165 induces progression of melanoma brain metastases without induction of sprouting angiogenesis","volume":"62","author":"K\u00fcsters","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2022.11.008_b0520","first-page":"534","article-title":"The role of VEGF in melanoma progression","volume":"17","author":"Rajabi","year":"2012","journal-title":"Journal of Research in Medical Sciences"},{"key":"10.1016\/j.jare.2022.11.008_b0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep06994","article-title":"Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production","volume":"4","author":"Kim","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2022.11.008_b0530","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajpath.2012.04.012","article-title":"Highly invasive melanoma cells activate the vascular endothelium via an MMP-2\/integrin \u03b1v\u03b25-induced secretion of VEGF-A","volume":"181","author":"Desch","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2022.11.008_b0535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/pcmr.12319","article-title":"Thrombospondin-1 is part of a Slug-independent motility and metastatic program in cutaneous melanoma, in association with VEGFR-1 and FGF-2","volume":"28","author":"Borsotti","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jare.2022.11.008_b0540","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jid.2016.10.038","article-title":"Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells","volume":"137","author":"Bauer","year":"2017","journal-title":"J, Invest Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0545","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jare.2022.11.008_b0550","doi-asserted-by":"crossref","unstructured":"So JY, Nazaroff J, Iwummadu C v., Harris N, Gorell ES, Fulchand S, et al. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa. Orphanet J Rare Dis 2022;17:377. https:\/\/doi.org\/10.1186\/S13023-022-02546-9.","DOI":"10.1186\/s13023-022-02546-9"},{"key":"10.1016\/j.jare.2022.11.008_b0555","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","article-title":"In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial","volume":"28","author":"Gurevich","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2022.11.008_b0560","doi-asserted-by":"crossref","first-page":"30661","DOI":"10.1021\/acsami.9b13135","article-title":"Efficient and Robust Highly Branched Poly(\u03b2-amino ester)\/Minicircle COL7A1 Polymeric Nanoparticles for Gene Delivery to Recessive Dystrophic Epidermolysis Bullosa Keratinocytes","volume":"11","author":"Zeng","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jare.2022.11.008_b0565","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/exd.13054","article-title":"A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa","volume":"25","author":"Cutlar","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jare.2022.11.008_b0570","article-title":"Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. JCI","volume":"4","author":"Lwin","year":"2019","journal-title":"Insight"},{"key":"10.1016\/j.jare.2022.11.008_b0575","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.ymthe.2017.08.015","article-title":"Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR\/Cas9 Nickases","volume":"25","author":"Kocher","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.jare.2022.11.008_b0580","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.omtm.2017.06.008","article-title":"Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients","volume":"6","author":"Aushev","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jare.2022.11.008_b0585","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/crispr.2021.0132","article-title":"Allele-Specific Inactivation of an Autosomal Dominant Epidermolysis Bullosa Simplex Mutation Using CRISPR-Cas9","volume":"5","author":"Bchetnia","year":"2022","journal-title":"CRISPR J"},{"key":"10.1016\/j.jare.2022.11.008_b0590","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1073\/pnas.1512028113","article-title":"Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa","volume":"113","author":"Shinkuma","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2022.11.008_b0595","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.ymthe.2022.06.005","article-title":"Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa","volume":"30","author":"Hong","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jare.2022.11.008_b0600","doi-asserted-by":"crossref","unstructured":"Petkovi\u0107 I, Bischof J, Kocher T, March OP, Liemberger B, Hainzl S, et al. COL17A1 editing via homology-directed repair in junctional epidermolysis bullosa. Front Med (Lausanne) 2022;9. https:\/\/doi.org\/10.3389\/FMED.2022.976604.","DOI":"10.3389\/fmed.2022.976604"},{"key":"10.1016\/j.jare.2022.11.008_b0605","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.ymthe.2022.04.020","article-title":"Paired nicking-mediated COL17A1 reframing for junctional epidermolysis bullosa","volume":"30","author":"Bischof","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jare.2022.11.008_b0610","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-020-00780-z","article-title":"Small-molecule MMP2\/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1","volume":"12","author":"Ye","year":"2020","journal-title":"Genome Med"},{"key":"10.1016\/j.jare.2022.11.008_b0615","doi-asserted-by":"crossref","unstructured":"Marconi C, Bianchini F, Mannini A, Mugnai G, Ruggieri S, Calorini L. Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells. Clinical & Experimental Metastasis 2007 25:3 2007;25:225\u201331. https:\/\/doi.org\/10.1007\/S10585-007-9136-0.","DOI":"10.1007\/s10585-007-9136-0"},{"key":"10.1016\/j.jare.2022.11.008_b0620","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.bbamcr.2017.06.009","article-title":"Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects","volume":"1864","author":"Levin","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.jare.2022.11.008_b0625","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1091\/mbc.E18-05-0319","article-title":"Cancer cells\u2019 ability to mechanically adjust to extracellular matrix stiffness correlates with their invasive potential","volume":"29","author":"Wullkopf","year":"2018","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jare.2022.11.008_b0630","doi-asserted-by":"crossref","unstructured":"Plou J, Juste-Lanas Y, Olivares V, del Amo C, Borau C, Garc\u00eda-Aznar JM. From individual to collective 3D cancer dissemination: roles of collagen concentration and TGF-\u03b2. Scientific Reports 2018 8:1 2018;8:1\u201314. https:\/\/doi.org\/10.1038\/s41598-018-30683-4.","DOI":"10.1038\/s41598-018-30683-4"},{"key":"10.1016\/j.jare.2022.11.008_b0635","first-page":"1","volume":"0475","author":"Lampi","year":"2018","journal-title":"Targeting extracellular matrix stiffness to attenuate disease : From molecular mechanisms to clinical trials"},{"key":"10.1016\/j.jare.2022.11.008_b0640","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/ijc.23147","article-title":"Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma","volume":"122","author":"Van Kempen","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2022.11.008_b0645","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8148","article-title":"Progression of melanoma is suppressed by targeting all transforming growth factor-\u03b2 isoforms with an Fc chimeric receptor","volume":"46","author":"Kodama","year":"2021","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jare.2022.11.008_b0650","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1158\/0008-5472.CAN-12-1444","article-title":"Halofuginone inhibits the establishment and progression of melanoma bone metastases","volume":"72","author":"Ju\u00e1rez","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2022.11.008_b0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090353","article-title":"Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2022.11.008_b0660","first-page":"9028","article-title":"Phase I\/II study of GC1008: A human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody (MAb) in patients with advanced malignant melanoma (MM) or renal cell carcinoma (RCC)","volume":"26","author":"Morris","year":"2008","journal-title":"Https:\/\/DoiOrg\/101200\/Jco20082615_suppl9028"},{"key":"10.1016\/j.jare.2022.11.008_b0665","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.15252\/emmm.201505061","article-title":"Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms","volume":"7","author":"Nystr\u00f6m","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jare.2022.11.008_b0670","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79721-0","article-title":"Intraperitoneal collagenase as a novel therapeutic approach in an experimental model of colorectal peritoneal carcinomatosis","volume":"11","author":"Garc\u00eda-Olmo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2022.11.008_b0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-022-01252-0","article-title":"Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy","volume":"15","author":"Jiang","year":"2022","journal-title":"J Hematol Oncol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123222002648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123222002648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:56:56Z","timestamp":1761857816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123222002648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":135,"alternative-id":["S2090123222002648"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2022.11.008","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular matrix in skin diseases: The road to new therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2022.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}